Rowlett, TX, April 12, 2023 — McapMediaWire — Right on Brands, Inc. (OTC: RTON), a leader and innovator of HEMP DERIVED, and WELLNESS products announced today that its Board of Directors has approved an investment in Neuro Science Research Centers Inc.
Neuro Science Research Centers Inc. was formed to be one of the first licensed Psilocybin extraction facilities in Oregon. Psilocybin is being used to treat mental disorders and is shown to be of great benefit. The Johns Hopkins Center for Psychedelic and Consciousness Research is leading the way in exploring innovative treatments using psilocybin. The molecular structure of psilocybin, a naturally occurring psychedelic compound found in ‘magic mushrooms,’ allows it to penetrate the central nervous system and the scientific and medical experts are just beginning to understand its effects on the brain and mind and its potential as therapeutics for mental illnesses. Many other researchers and companies are looking to use these new products that will come from Psilocybin.
Jerry Grisaffi, President, and CEO of Right on Brands, stated, “We are excited to be entering into this relationship and partnership with Neuro Science Research Centers. Psilocybin research is still in its infancy, but with the level of production already accomplished and continued acceptance within the medical community using psilocybin, we believe this is an opportunity for us to be on the ground level, yet with our locations and distribution network we will be able to attain early success within a reasonable timeframe.” Russel Young has been named President of the new entity and majority shareholder Mike Brown has been name Secretary and Director. “This is a great opportunity, and I too am excited about our relationship with Right on Brands Inc.” states Russel.
Right on Brands, Inc., is a consumer goods company specializing in the brand development and distribution of hemp-based foods, beverages, smokables, oils and topical products. Right on Brands, Inc. is a developer of a broad line of hemp-based smokables, beverages, tinctures, and topical products including products infused with CBD, Delta-8, Delta-10, THCV, CBDV, and Delta-9 (below the federal limit) and the all new HHC vapes, gummies and tinctures. We will also be launching a Kratom gummy. About ENDO Brands: ENDO Brands, Humbly Hemp®, and ENDO Dispensary & Wellness Endo Franchise Group Inc, all share the same goal of providing our customers with the best products in the health and wellness space. As the field of health and wellness Endo’s approach is to give their customer a holistic approach to their wellness.
Corporate Sales Contact:
(214) 299-9528 / email@example.com
- ENDO Brands Corporate Store: ENDO Brands at Lakeview Plaza 6501 Dalrock Road, Suite 100 Rowlett, Texas 75089 214-299-9528
- AUSTIN LOCATION 12412 Limerick Avenue Austin, Texas 78758 www.endoofaustin.com 512-621-0649
- LAREDO LOCATION ENDO Laredo 2413 Jacaman Rd Laredo, Texas www.endolaredo.com 956-568-2300
- HOUSTON LOCATION 3301 Louetta Rd Ste 109 Spring, Texas 77388 Website coming soon. 832-583-5383
- MIAMI FLORIDA LOCATION 10850 SW 104th St Miami, Florida 33156 endo-miami.com 786-703-1276
- PLANO LOCATION 601 W. Parker Road Plano, Texas 75023 469-366-9694
- DALLAS LOCATION 9585 Scyene Road Dallas, Texas website coming soon.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the SEC. The forward-looking information provided herein represents the Company’s estimates as of the date of this press release, and subsequent events and developments may cause the Company’s estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.
Investor Relations Contact
516-662-9461 / firstname.lastname@example.org